Journals / Kafkas Üniversitesi Veteriner Fakültesi Dergisi / 2008 / Cilt: 14 - Sayı: 1

The treatment of transmissible venereal tumor (TUT) with vincristine sulphate in a male dog

Bir erkek köpekte transmissible venereal tümör (TUT) olgusunun vincristine sulphate ile sağaltımı

Pages
105–108
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case, it was aimed to show that cytological examinations in a male dog with TVT is required for definite diagnosis and alteration of blood parameters during treatment with appropriate doses of vincristine sulphate.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Summary In this study, we investigated the clinical, cytological and haemotological changes in after weekly vincristine sulphate administration in naturally occured a four year old male dog referred to Kırıkkale Univercity Clinics of Veterinary Faculty with history of haematuri.
📊
Key Findings & Data:Physical examination revealed cauliflower like appereance, 8 cm diameter haemorrhagical mass on bulbus penis.
💡
Conclusion & Impact:In this case, it was aimed to show that cytological examinations in a male dog with TVT is required for definite diagnosis and alteration of blood parameters during treatment with appropriate doses of vincristine sulphate.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:antineoplastik ajanlar · köpek · ilaç tedavisi

Abstract

Summary In this study, we investigated the clinical, cytological and haemotological changes in after weekly vincristine sulphate administration in naturally occured a four year old male dog referred to Kırıkkale Univercity Clinics of Veterinary Faculty with history of haematuri. Physical examination revealed cauliflower like appereance, 8 cm diameter haemorrhagical mass on bulbus penis. The diagnosis of TVT was established on the basis of cytologic results and clinical symptom. Treatment was considered of intravenous 0.025 mg/kg vincristine sulphate in 500 ml saline solution. The treatment was conducted one a week for a duration of six week. In this case, it was aimed to show that cytological examinations in a male dog with TVT is required for definite diagnosis and alteration of blood parameters during treatment with appropriate doses of vincristine sulphate.

Özet

Özet Bu çalışmada, Kırıkkale Üniversitesi Veteriner Fakültesi Kliniğine hematüri şikayetiyle getirilen 4 yaşlı doğal olarak enfekte Boxer ırkı erkek bir köpekte haftalık vincristine sülfat uygulaması sonrası klinik, sitolojik ve hematolojik değişimler araştırıldı. Hayvanın klinik muayenesinde bulbus penis üzerinde kanamalı, karnıbahar görünümünde, yaklaşık 8 cm çapında bir kitle tespit edildi. Klinik tanı ve sitolojik sonuçlar baz alınarak TVT tanısı konuldu. Tedavide 0.025 mg/kg dozunda vincristine sulphate 500 ml serum fizyolojik ile birlikte uygulandı. Tedavi haftalık kürler halinde altı hafta sürdürüldü. Bu çalışmada erkek köpeklerde TVT'nin kesin tanısında sitolojik incelemenin gerekliliği ve tedavide vincristine sülfatın uygun dozlarda kullanımında kan parametrelerindeki oluşan değişimler ortaya konulmaya çalışılmıştır.

🔖

Cite This Article

YAĞCI, İ. P., KALENDER, H. (2008). The treatment of transmissible venereal tumor (TUT) with vincristine sulphate in a male dog. Kafkas Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 14 - Sayı: 1, 105–108. https://ajindex.com/articles/273888

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. KAYNAKLAR 1. Boscos CM, Ververidis HN: Canine TVT: Clinical findings, diagnosis and treatment. Erişim adresi: http: //www.vin.com/proceed ings/ Proceed i ngs.plx?CID= WSAVA2004&PID=8752&O =Generic. Erişim tarihi: 29.01.08,2004. 2. Mello Martins MI, Ferreira de Souza F, Gobello C: Canine transmissible venereal tumor: etiology, pathology, diagnosis and treatment Erişim adresi:http://www. ivis.org/advances/ Concannon/gobello2/chapter. asp?LA=1. Erişim tarihhli.N.2008, 2005. 3. Baştan A: Köpeklerde transmissible venereal tümörler. Ankara Böl Vet Hek Odası D erg, Temmuz, 53-56, 1996. 4. Bush BM: Interpretation of laboratory results for small animal clinicians. In, Bush BM (Ed): 478-479,
  2. Blackwell Scientific Publication, Oxford, 1993. 5. Ünal ÜA: Transmissible tümörlü dişi köpeklerde önemli etiyolojik faktörler ve uygulanan tedavi yöntemlerine ilişkin incelemeler. Ankara Üniversitesi Sağlık Bilimleri Enstitüsü. Tezsiz Yüksek Lisans Dönem Ödevi) 2003. 6. Tilley LP, Smith FWK: Transmissible venereal tumor. In, Cann C (Ed): The 5 Minute Veterinary Consult Canine and Feline. 1st ed, 1118. Williams and Wilkins, Maryland, 1997. 7. Feldman EC, Nelson RW: Brucellosis and transmissible venereal tumor. In, Feldman FC, Nelson RW (Eds): Canine and Feline Endocrinoloji and Reproduction. 2nd edition, 669-671.
  3. W.B. Saunders Company, Philadelphia, 1996. 8. Nak D, Nak Y, Cangiil IT, Tuna B: A clinico-pathological study on the effect of vincristine on transmissible venereal tumor in dogs. J Vet Med, 52, 366-370, 2005. 9. Telia MA, Ajala OO, Taiwo VO: Complete regression of transmissible venereal tumour (TVT) in nigerian mongrel dogs with vincristine sulphate chemotherapy. Afr J BiomedRes, 7 (3): 133-138, 2004.